HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
TuHURA Biosciences, Inc./NV
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.78+0.02 (+1.14%)
Close on Oct 19, 2026
- Market cap
- $113.86M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
-$30.05MFY2025